V

Verastem
D

VSTM

5.68500
USD
0.12
(2.06%)
مغلق
حجم التداول
12,711
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
253,019,600
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMA
    -0.238
    (-1.48%)
    15.835 USD
    C
    CTMX
    -0.03570
    (-4.38%)
    0.78000 USD
    E
    EXEL
    1.750
    (4.99%)
    36.830 USD
    I
    IMMP
    -0.06000
    (-3.03%)
    1.92000 USD
    I
    IONS
    -0.365
    (-1.12%)
    32.310 USD
    M
    MNOV
    0.07000
    (3.98%)
    1.83000 USD
    T
    TGTX
    -0.040
    (-0.13%)
    30.900 USD
    المزيد
الأخبار
المقالات

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.